IC
TENX icon

Ikarian Capital’s Tenax Therapeutics TENX Stock Holding History

Ikarian Capital’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83M Buy
+114,300
New +$1.55M 0.15% 101

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Ikarian Capital's TENX Position: Q1 2026 in Review

Ikarian Capital increased its Tenax Therapeutics (TENX) stake by 5.2% in Q1 2026, buying an estimated $676K and bringing the position to 1,017,600 shares worth $16.3M. The position accounts for 1.32% of the portfolio, ranked #17.

Ikarian Capital first reported a position in TENX in Q3 2021 and has held it in 6 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Ikarian Capital held 1,017,600 shares of Tenax Therapeutics worth $16.3M as of Q1 2026.
  • Ikarian Capital bought 50,000 Tenax Therapeutics shares in Q1 2026, an estimated $676K.
  • Tenax Therapeutics made up 1.32% of Ikarian Capital's portfolio in Q1 2026, its #17 holding.
  • Ikarian Capital first reported a position in Tenax Therapeutics in Q3 2021 and has held it in 6 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.